|
Timothy Morris, MD
Director, Pulmonary Clinical Programs
UCSD Medical Center - Hillcrest
Associate Professor of Medicine
Medical Director, Respiratory Care
Medical Director, Pulmonary Function Laboratory
|
President, California
Thoracic Society 2003-2004
|
|
|
|
|
|
|
|
Distinguished Scholar in Thrombosis,
American College of Chest Physicians 2003-2006 (inaugural awardee)
|
|
|
|
|
|
|
|
Chairman, Department of Medicine Continuous Quality
Improvement Committee Department of Medicine. Housestaff Teaching Awards
1995, 1996, 1997, 1998, 1999, 2001, 2002
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CLINICAL INTERESTS:
| 1. |
General pulmonary medicine |
| 2. |
Acute pulmonary thromboembolic disease |
| 3. |
Critical Care |
INVESTIGATIVE INTERESTS:
Acute pulmonary thromboembolic disease
SELECTED PUBLICATIONS:
| 1. |
Morris TA, Auger WR, Ysrael MZ, Olson LK, Channick RN,
Fedullo PF, Moser KM. Parenchymal scarring is associated with
|
|
restrictive spirometric
defects in patients with chronic thromboembolic pulmonary hypertension. Chest
1966;110:399-403.
|
| 2.
|
Morris TA, Ysrael MZ, Olson LK, Auger WR, Fedullo PF,
Moser KM. Restrictive spirometric defect in patients with chronic
|
|
|
pulmonary thromboembolic
hypertension. Chest 1992;102(2):120s.
|
| 3.
|
Morris TA, March JJ, Konopka RG, Pedersen CA, Chiles PG,
Moser KM. Antifibrin monoclonal antibodies detect deep
|
|
|
vein thrombosis in a canine model.
Chest 1993;104(5):24s.
|
| 4.
|
Yi ES, Auger WR, Friedman PJ, Morris TA, Shin SS.
Intravascular bronchoalveolar tumor of the lung presenting as
|
|
|
pulmonary thromboembolic
disease and pulmonary hypertension. Arch Pathol Lab Med 1995;119:225-60.
|
| 5. |
Morris TA. Pulmonary complications in burn patients
(previously "inhalation injury"). In Manual of Clinical Problems in
|
|
Pulmonary Medicine, 4th Edition. Bordow RA, Moser KM, editors. Boston: Little, Brown &
Company. pp. 376-81, 1996.
|
| 6.
|
Morris TA. Histoplasmosis. In Manual of Clinical
Problems in Pulmonary Medicine, 4th Edition. Bordow RA, Moser KM,
|
|
|
editors. Boston: Little,
Brown & Company. pp. 156-60, 1996.
|
| 7.
|
Morris TA, Marsh JJ, Konopka R, Pedersen CA, Chiles PG,
Fagnani R, Hagan M, Moser KM. Antibodies against the fibrin
|
|
|
-chain amino terminus detect
active canine venous thrombi. Circulation 1997;96(9):3173-9.
|
| 8. |
Morris TA, Marsh JJ, Fagnani R, Hagan M, Moser KM. Degree
of polymer organization decreases the binding of a monoclonal |
|
|
antibody raised against the -chain amino terminus of fibrin.
Thromb Haemost 1997;77:704-9.
|
|
9.
|
Morris TA,
J.J.;Chiles, P.G.;Pedersen, C.A.;Konopka, R.G.;Gamst, A.C.; Loza, O.
Embolization Itself Stimulates Thrombus
|
|
|
Propagation in Pulmonary Embolism. Am J
Physiol Heart Circ Physiol. 2004;in press.
|
|
10
|
Morris TA, Marsh JJ, Chiles PG, Konopka RG, Pedersen CA, Schmidt
PF, Gerometta M. Single Photon Emission
|
|
|
Computed Tomography of Pulmonary Emboli
and Venous Thrombi Using Anti-D-dimer. Am J Respir Crit Care Med. 2004.in
press.
|
|
11.
|
Morris TA, Marsh JJ, Burrows CM, Chiles PG, Konopka RG, Pedersen
CA. Urine and plasma levels of fibrinopeptide B
|
|
|
in patients with deep vein
thrombosis and pulmonary embolism. Thromb Res. 2003;110:159-65.
|
|
12.
|
Morris TA. Heparin and low molecular weight
heparin: background and pharmacology. Clin Chest Med JID -
|
|
|
7907612.
2003;24:39-47.
|
|
13.
|
Morris TA. Diagnostic Test for Thrombotic or Thromboembolic Disease.
In: Regents of the University of California; 2003.
|
|
14.
|
Morris TA.
Thromboembolic Disease - Epidemiology, Natural History and Diagnosis. In:
Bordow RA, Ries AL, Morris TA,
|
|
|
eds. Manual of Clinical Problems in Pulmonary
Medicine. 5 ed. Philadelphia: Lippincott Williams & Wilkins;
2001:321-328.
|
|
15.
|
Hyers TM, Agnelli G, Hull RD, Morris
TA, Samama M, Tapson V, Weg JG. Antithrombotic therapy for venous
|
|
|
thromboembolic disease. Chest JID - 0231335. 2001;119:176S-193S.
|
|
16.
|
Yi ES, Kim H, Ahn H, Strother
J, Morris T, Masliah E, Hansen LA, Park K, Friedman PJ. Distribution
of obstructive intimal
|
|
|
lesions and their cellular phenotypes in chronic
pulmonary hypertension. A morphometric and immunohistochemical study.
|
|
|
American Journal of Respiratory and Critical Care Medicine.
2000;162:1577-1586.
|
|
17.
|
Morris TA, Marsh
JJ, Konopka R, Pedersen CA, Chiles PG. Anti-thrombotic efficacies of
enoxaparin, dalteparin, and
|
|
|
unfractionated eparin in venous thrombo-embolism. Thromb Res JID -
0326377. 2000;100:185-194
|
|
18.
|
Tapson VF, Carroll BA, Davidson
BL, Elliott CG, Fedullo PF, Hales CA, Hull RD, Hyers TM, Leeper KJ, Morris
TA,
|
|
|
Moser KM, Raskob GE, Shure D, Sostman HD, Taylor T. The diagnostic
approach to acute venous thromboembolism. Clinical
|
|
|
practice guideline.
American Thoracic Society. American Journal of Respiratory and Critical
Care Medicine. 1999;160:1043-1066.
|
|
19.
|
Kim H, Yung GL, Marsh JJ,
Konopka RG, Pedersen CA, Chiles PG, Morris TA, Channick RN. Endothelin
mediates pulmonary
|
|
|
vascular remodelling in a canine model of chronic embolic
pulmonary hypertension. European Respiratory Journal. 2000;15:640-648.
|
|
20.
|
Kim H, Yung GL, Morris TA,
Marsh JJ, Chiles P, Pedersen C, Konopka R, Channick R. Endothelin Antagonism
Inhibits
|
|
|
Pulmonary Vascular Remodeling In Canine Chronic Pulmonary
Embolism. American Journal of Respiratory and Critical Care
|
|
|
Medicine.
1999;159:566.
|
|
21.
|
Kim H, Yung GL, Marsh JJ,
Konopka RG, Pedersen CA, Chiles PG, Morris TA, Channick RN.
Pulmonary vascular remodeling
|
|
|
distal to pulmonary artery ligation is
accompanied by upregulation of endothelin receptors and nitric oxide
synthase. Experimental Lung
|
|
|
Research. 2000;26:287-301.
|
|
22.
|
Morris TA, Marsh JJ, Konopka R, Pedersen CA, Chiles PG, Fagnani R,
Hagan M, Moser KM. Antibodies against the fibrin
|
|
|
beta-chain amino-terminus
detect active canine venous thrombi. Circulation. 1997;96:3173-3179.
|
|
23.
|
Morris TA, Marsh JJ, Fagnani R, Hagan M, Moser KM. Degree of polymer
organization decreases the binding of a monoclonal
|
|
|
antibody raised against
the beta-chain amino terminus of fibrin. Thrombosis and Haemostasis.
1997;77:704-709.
|
|
24.
|
Morris TA, Auger WR, Ysrael MZ, Olson LK, Channick RN, Fedullo PF,
Moser KM. Parenchymal scarring is associated
|
|
with restrictive spirometric
defects in patients with chronic thromboembolic pulmonary hypertension.
Chest. 1996;110:399-403. |
For more information write to tlmorris@ucsd.edu
|
For appointments contact: Donna Raymond
200 West Arbor Drive, 8372
San Diego, CA 92103
(619)543-5972
draymond@ucsd.edu |
|
